Engineering of pectin-capped gold nanoparticles for delivery of doxorubicin to hepatocarcinoma cells: an insight into mechanism of cellular uptake

References

• Han G, Ghosh P, Rotello V. Functionalized gold nanoparticles for drug delivery. Nanomedicine. 2007;2:113–123.
   PubMed Web of Science ®Google Scholar
• Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev. 2002;54:631–651.
   PubMed Web of Science ®Google Scholar
• Beik J, Jafariyan M, Montazerabadi A, et al. The benefits of folic acid-modified gold nanoparticles in CT-based molecular imaging: radiation dose reduction and image contrast enhancement. Artif Cells Nanomed Biotechnol. 2017 [Dec 12]; [1–9]. DOI:10.1080/21691401.2017.1408019
   PubMed Web of Science ®Google Scholar
• Daraee H, Eatemadi A, Abbasi E, et al. Application of gold nanoparticles in biomedical and drug delivery. Artif Cells Nanomed Biotechnol. 2016;44:410–422.
   PubMed Web of Science ®Google Scholar
• Parker JF, Fields-Zinna CA, Murray RW. The story of a monodisperse gold nanoparticle: Au25L18. Acc Chem Res. 2010;43:1289–1296.
   PubMed Web of Science ®Google Scholar
• Ghosh P, Han G, De M, et al. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev. 2008;60:307–1315.
   Web of Science ®Google Scholar
• Connor EE, Mwamuka J, Gole A, et al. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small. 2005;1:325–327.
   PubMed Web of Science ®Google Scholar
• Versiani A, Andrade M, Martins E, et al. Gold nanoparticles and their applications in biomedicine. Future Virol. 2016;11:293–309.
   Web of Science ®Google Scholar
• Polte J, Ahner TT, Delissen F, et al. Mechanism of gold nanoparticle formation in the classical citrate synthesis method derived from coupled in situ XANES and SAXS evaluation. J Am Chem Soc. 2010;132:1296–1301.
   PubMed Web of Science ®Google Scholar
• Rouhana LL, Jaber JA, Schlenoff JB. Aggregation-resistant water-soluble gold nanoparticles. Langmuir. 2007;23:12799–12801.
   PubMed Web of Science ®Google Scholar
• Singh P, Kim YJ, Yang DC. A strategic approach for rapid synthesis of gold and silver nanoparticles by Panax ginseng leaves. Artif Cells Nanomed Biotechnol. 2016;44:1949–1957.
   PubMed Web of Science ®Google Scholar
• Huo Y, Singh P, Kim YJ, et al. Biological synthesis of gold and silver chloride nanoparticles by Glycyrrhiza uralensis and in vitro applications. Artif Cells Nanomed Biotechnol. 2018;46:303–312.
   PubMed Web of Science ®Google Scholar
• Dhar S, Reddy EM, Shiras A, et al. Natural gum reduced/stabilized gold nanoparticles for drug delivery formulations. Chem Eur J. 2008;14:10244–10250.
   PubMed Web of Science ®Google Scholar
• Pooja D, Panyaram S, Kulhari H, et al. Xanthan gum stabilized gold nanoparticles: characterization, biocompatibility, stability and cytotoxicity. Carbohydr Polym. 2014;110:1–9.
   PubMed Web of Science ®Google Scholar
• Joshi HM, Bhumkar DR, Joshi K, et al. Gold nanoparticles as carriers for efficient transmucosal insulin delivery. Langmuir. 2006;22:300–305.
   PubMed Web of Science ®Google Scholar
• Borker S, Patole M, Moghe A, et al. Engineering of pectin-reduced gold nanoparticles for targeted delivery of an antiviral drug to macrophages: in vitro and in vivo assessment. Gold Bull. 2017;50:235–246.
   Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.
   Google Scholar
• World Health Organization. Cancer factsheet. 2018. Available from: http://www.who.int/en/news-room/fact-sheets/detail/cancer (last accessed 22 January 2018).
   Google Scholar
• Ahluwalia SC, Chuang FL, Antonio AL, et al. Documentation and discussion of preferences for care among patients with advanced cancer. J Oncol Pract. 2012;7:361–366.
   Google Scholar
• Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer. 2005;5:161–171.
   PubMed Web of Science ®Google Scholar
• Yang T, Wang C, Hsieh R, et al. Gemcitabine and doxorubicin for the treatment of patients with advanced hepatocellular carcinoma: a phase I-II trial. Ann Oncol. 2002;13:1771–1778.
   PubMed Web of Science ®Google Scholar
• Park J, Fong P, Lu J, et al. PEGylated PLGA nanoparticles for the improved delivery of doxorubicin. Nanomedicine. 2009;5:410–418.
   PubMed Web of Science ®Google Scholar
• D’Souza AA, Devarajan PV. Asialoglycoprotein receptor mediated hepatocyte targeting – strategies and applications. J Control Rel. 2015;203:126–139.
   PubMed Web of Science ®Google Scholar
• Diaz C, Vargas E, Gatijens BO. Cytotoxic effect induced by retinoic acid loaded into galactosyl sphingosine containing liposomes on human hepatoma cell lines. Int J Pharm. 2006;325:108–115.
   PubMed Web of Science ®Google Scholar
• Pranatharthiharan S, Patel MD, Malshe VC, et al. Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma. Drug Deliv. 2017;24:20–29.
   PubMed Web of Science ®Google Scholar
• Yu CY, Wang YM, Li NM, et al. In Vitro and in vivo evaluation of pectin-based nanoparticles for hepatocellular carcinoma drug chemotherapy. Mol Pharm. 2014;11:638–644.
   PubMed Web of Science ®Google Scholar
• Garg M, Madan J, Pandey RS, et al. Galactosylated gelatin nanovectors of doxorubicin inhibit cell proliferation and induce apoptosis in hepatocarcinoma cells. Anticancer Drugs. 2012;23:836–845.
   PubMed Web of Science ®Google Scholar
• Wei M, Xu Y, Zou Q, et al. Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin. Eur J Pharm Sci. 2012;46:131–141.
   PubMed Web of Science ®Google Scholar
• Chopdey PK, Tekade RK, Mehra NK, et al. Glycyrrhizin conjugated dendrimer and multi-walled carbon nanotubes for liver specific delivery of doxorubicin. J Nanosci Nanotechnol. 2015;15:1088–1100.
   PubMed Web of Science ®Google Scholar
• Chithrani DB, Chan CWC. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 2007;7:1542–1550.
   PubMed Web of Science ®Google Scholar
• Lasagna-Reeves C, Gonzalez-Romero D, Barria MA, et al. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Commun. 2010;393:649–655.
   PubMed Web of Science ®Google Scholar
• Huang G, Diakur J, Xu Z, et al. Asialoglycoprotein receptor-targeted superparamagnetic iron oxide nanoparticles. Int J Pharm. 2008;360:197–203.
   PubMed Web of Science ®Google Scholar
• Mulvaney P. Surface plasmon spectroscopy of nanosized metal particles. Langmuir. 1996;12:788–800.
   Web of Science ®Google Scholar
• Teodora M. Hemolysis as expression of nanoparticles-induced cytotoxicity in red blood cells. Biotechnol Mol Biol Nanomed. 2013;1:7–12.
   Google Scholar
• Goodman CM, McCusker CD, Yilmaz T, et al. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem. 2004;15:897–900.
   PubMed Web of Science ®Google Scholar
• Wang F, Wang YC, Dou S, et al. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. ACS Nano. 2011;5:3679–3692.
   PubMed Web of Science ®Google Scholar